Results

Total Results: 744 records

Showing results for "presence".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_research-protocol.pdf
    December 09, 2013 - current health states Settings Decision aids used for health care or legal settings, whether in the presence … the decisions under consideration and the possibility of the decision aids being used without the presence
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - score >4; medical stable (COWS score ≤5, no acute opioid withdrawal); resident of one of two counties; presence … Race/ethnicity White: 83% Black: 10% Other: 6% Female: 83% Long-term opioid therapy defined as the presence
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
    September 29, 2011 - Clinical presentations CAD is the presence of atherosclerosis in the epicardial coronary arteries … antithrombin and antiplatelet therapies should be administered to all patients regardless of the presence … literature by abstracting relevant continuous (e.g., age, event rates) and categorical data (e.g., race, presence … Additionally, when appropriate, the studies will be evaluated for dose-response association, the presence
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
    June 01, 2013 - account the size of the primary tumor (T), the extent of regional lymph node involvement (N), and the presence … emission tomography (FDG PET), computed tomography (CT), or magnetic resonance imaging (MRI).5 The presence … patients who refuse surgery, or patients with inoperable NSCLC who have symptoms secondary to the presence … local nonsurgical therapies in patients with inoperable NSCLC who have symptoms secondary to the presence … of contraindications to major surgery—for example, cardiac insufficiency, poor pulmonary function, presence
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-app-protocol-updated.pdf
    January 01, 2018 - Depending on the structure of the final framework, apps will receive a score of “1” to indicate the presence … Depending on the structure of the final framework, apps will receive a score of “1” to indicate the presence
  6. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/tympanostomy-tubes_research-protocol.pdf
    November 16, 2015 - Acute otitis media (AOM) is defined as the presence of fluid in the middle ear with signs and symptoms … Otitis media with effusion (OME) is defined as the presence of fluid in the middle ear behind an intact … What factors (such as age, age of onset, number of recurrences, presence of persistent middle ear effusion
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-strength_methods.pdf
    July 01, 2009 - • Additional domains to be used when appropriate include dose-response association, presence of confounders … incorporate not only study design but also many other facets of the evidence, including study conduct, presence … The presence of inconsistency is the chief concern for grading strength of evidence in this domain, … Presence of a clear dose- response association or a very strong association would justify increasing
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
    March 14, 2012 - gastroparesis has been defined as delayed gastric emptying as detected by clinical testing and the presence … consideration for compassionate use of gastric pacer therapy, one of the key eligibility criteria is the presence … Outlet dysfunction, a category of slow-transit constipation, is the presence of discoordinated motion … If testing confirms the presence of slow-transit constipation (colonic inertia) without use of laxatives
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol-amendment.pdf
    January 08, 2025 - ability of statistical methods to detect individual sources of heterogeneity may be limited in the presence … health (e.g., socioeconomic status; race/ethnicity and culture) as reported in the literature, and the presence … recommended or commonly used in practice, dosing of medications not reflective of current practice, the presence … of co-interventions that are likely to modify the effectiveness, and the presence of highly trained … There are also situations where evidence may be upgraded (e.g., large magnitude of effect, presence
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol.pdf
    June 10, 2024 - ability of statistical methods to detect individual sources of heterogeneity may be limited in the presence … health (e.g., socioeconomic status; race/ethnicity and culture) as reported in the literature, and the presence … recommended or commonly used in practice, dosing of medications not reflective of current practice, the presence … of co-interventions that are likely to modify the effectiveness, and the presence of highly trained … There are also situations where evidence may be upgraded (e.g., large magnitude of effect, presence
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
    September 25, 2013 - Reviewers 2, 3, 4 General Comments The strength of evidence to support an association between the presence … This detracts from the lack of robustness certainty surrounding these estimates given the presence … LTA is based on the principle that platelets will aggregate in the presence of an agonist. … The specimen is incubated with a high concentration of PGE1 in the presence and absence of ADP. … Based on the presence of a measurable drug effect, one would expect that the antiplatelet effect would
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/joint-replacement-evidence%20-summary.pdf
    November 01, 2021 - )rehabilitation intervention components at the level of goals (e.g., strength, flexibility) or the presence
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
    May 20, 2013 - “T”), the extent of local or regional lymph node spread (nodal stage, designated as “N”), and the presence … the setting of colorectal cancer staging, TUS is mainly used to image the liver for the potential presence … can produce false-negative results in metabolically inactive tumors or false-positive results in the presence … information on the “local stage” (i.e., the depth to which the cancer invades the bowel wall) but not on the presence … Publication bias will be addressed by noting the presence of abstracts or ClinicalTrials.gov entries
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-hospitalizations_research.pdf
    October 01, 2008 - by the identification/isolation of specific organisms from tissue, fluid or body cavity or by the presence … determination would require review of all or at least a random sample of medical records without regard to presence
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
    February 22, 2012 - T2N0M0) NSCLC in adult patients (age 18 years or older) who are not surgical candidates because of the presence … of contraindications to major surgery, for example, cardiac insufficiency, poor pulmonary function, presence … I (T1N0M0 and T2N0M0) NSCLC who: ○ Are not deemed surgical candidates because of the documented presence … contraindications to major surgery, for example, cardiac insufficiency, poor pulmonary function, presence
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
    December 23, 2014 - Use of the term CDI indicates the major focus of this review is on the presence of clinical disease, … There are increasing numbers of diagnostic tests designed to detect either the presence of the organism … tests rely on two-step procedures, making use of sensitive, inexpensive, fast screening tests for the presence … that may be considered in assessing strength of evidence include dose-response relationship, the presence
  17. effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
    May 01, 2021 - We included experimental and observational studies with a comparator that reported the presence or absence … Limitations Our review of the literature was extensive and designed to capture available evidence on the presence
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - Exclusion: Presence of systemic inflammatory arthritis, taking oral steroids in the last three months … , intra-articular corticosteroid injection for knee in the last six months, presence of neurological … deficit in the lower extremity, history of knee surgery, presence of central or peripheral nervous system … ; and (3) providing the exclusion criteria: (1)participation in a concurrent treatment trial; (2) presence … during the last 12 months; (4) previous experience in meditation or other mind-body therapies; (5) presence
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - Exclusion: Presence of systemic inflammatory arthritis, taking oral steroids in the last three months … , intra-articular corticosteroid injection for knee in the last six months, presence of neurological … deficit in the lower extremity, history of knee surgery, presence of central or peripheral nervous system … ; and (3) providing the exclusion criteria: (1)participation in a concurrent treatment trial; (2) presence … during the last 12 months; (4) previous experience in meditation or other mind-body therapies; (5) presence
  20. effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
    October 01, 2010 - Generally, a fixed effects model is not advised in the presence of significant heterogeneity. … A test for the presence of statistical heterogeneity, for example, Cochran‘s Q test, as well as a measure … In the absence of sufficient direct head-to-head evidence and presence of sufficient indirect evidence … unmitigated failure:‘ number- needed-to-treat-related concepts for assessing treatment efficacy in the presence

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: